Skip to content

BioSig Technologies, Inc. STEX Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$46.69M+89.0%-$424.01M-2,621%-$15.58M+23.5%-$20.37M-627%-$2.8M-155%
$1.49M+1.6%$1.47M-1.3%$1.49M+169%$554K+2,538%$21K-30.0%
$25.37M-48.0%$48.82M+5,698%$842K-84.3%$5.37M+159%$2.07M
-$10.18M-237%-$3.02M+39.9%-$5.02M-293%-$1.28M-14.6%-$1.12M-135%
-$1.5M+93.9%-$24.47M
$11.34M0.0%$11.34M0.0%$11.34M0.0%$11.34M
$2.01M0.0%$2.01M0.0%$2.01M0.0%$2.01M
-$1.64M-104%$36.78M+175%$13.4M$0-100%$4.7M+469,900%
-$13.46M-245%$9.27M+12.7%$8.23M$0-100%$3.59M+858%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does BioSig Technologies, Inc. generate?
BioSig Technologies, Inc. (STEX) generated -$19.5M in operating cash flow over the trailing twelve months.
Where does BioSig Technologies, Inc.'s cash flow data come from?
Every line is extracted from BioSig Technologies, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.